analyze and study fentanyl-related substances expeditiously and that the scientific community be able to research these substances in order to develop life-saving antidotes and treatments. The most promising life-saving antidotes and treatments for fentanyl addiction and overdose are likely to share molecular properties with fentanyl and its related substances. 3. Definitions In this Act: (1) Evaluation The term evaluation means a scientific and medical evaluation, as conducted by the Secretary of Health and Human Services at the request of the Attorney General, and the recommendations as to whether such drug or other substance should be so controlled or removed as a controlled substance from the schedules pursuant to section 201(b) of the Controlled Substances Act ( 21 U.S.C. 811(b) ). (2) Fentanyl-related substance The term fentanyl-related substance has the meaning given the term in section 1308.11 of title 21, Code of Federal Regulations. 4. Evaluation of encountered fentanyl-related substances (a) Identified substances (1) In general The Attorney General shall complete the proceedings to schedule or transfer between schedules, or remove any fentanyl-related substances from the schedules pursuant to subsection (k) of section 201 of the Controlled Substances Act ( 21 U.S.C. 811 ), as added by section 5 of this Act— (A) not later than 1 year after the date of enactment of this Act for each fentanyl-related substance that— (i) the Drug Enforcement Administration has identified, as of the date of enactment of this Act